These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19059449

  • 1. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
    Torres KC, Souza BR, Miranda DM, Nicolato R, Neves FS, Barros AG, Dutra WO, Gollob KJ, Correa H, Romano-Silva MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):214-9. PubMed ID: 19059449
    [Abstract] [Full Text] [Related]

  • 2. Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients.
    Torres KC, Souza BR, Miranda DM, Sampaio AM, Nicolato R, Neves FS, Barros AG, Dutra WO, Gollob KJ, Correa H, Romano-Silva MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):229-34. PubMed ID: 19091302
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M, Mizukami K, Iwakiri M, Asada T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1177-81. PubMed ID: 17521792
    [Abstract] [Full Text] [Related]

  • 4. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR.
    Mol Psychiatry; 2009 Jun 15; 14(6):601-13. PubMed ID: 18268500
    [Abstract] [Full Text] [Related]

  • 5. [DARPP-32 in the patients with endogenous psychosis].
    Ishikawa M, Mizukami K.
    Brain Nerve; 2007 Nov 15; 59(11):1257-63. PubMed ID: 18044203
    [Abstract] [Full Text] [Related]

  • 6. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
    Ding L, Hegde AN.
    Biol Psychiatry; 2009 Mar 15; 65(6):541-5. PubMed ID: 19041089
    [Abstract] [Full Text] [Related]

  • 7. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
    Kunii Y, Yabe H, Wada A, Yang Q, Nishiura K, Niwa S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1139-43. PubMed ID: 21453742
    [Abstract] [Full Text] [Related]

  • 8. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJ, Birkenhäger TK, Bergink V, Drexhage HA.
    Brain Behav Immun; 2011 Aug 01; 25(6):1162-9. PubMed ID: 21421043
    [Abstract] [Full Text] [Related]

  • 9. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I, DeRuyter M, Rummens JL, Bosmans E, Maes M.
    Neuro Endocrinol Lett; 2007 Aug 01; 28(4):477-83. PubMed ID: 17693977
    [Abstract] [Full Text] [Related]

  • 10. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.
    Boneberg EM, von Seydlitz E, Pröpster K, Watzl H, Rockstroh B, Illges H.
    J Neuroimmunol; 2006 Apr 01; 173(1-2):180-7. PubMed ID: 16376996
    [Abstract] [Full Text] [Related]

  • 11. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.
    Carrard A, Salzmann A, Malafosse A, Karege F.
    J Affect Disord; 2011 Aug 01; 132(3):450-3. PubMed ID: 21453976
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
    Kunii Y, Hyde TM, Ye T, Li C, Kolachana B, Dickinson D, Weinberger DR, Kleinman JE, Lipska BK.
    Mol Psychiatry; 2014 Feb 01; 19(2):192-9. PubMed ID: 23295814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL, Llenos IC, Dulay JR, Weis S.
    Brain Res; 2006 Feb 16; 1073-1074():25-37. PubMed ID: 16448631
    [Abstract] [Full Text] [Related]

  • 16. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
    Sakai T, Oshima A, Nozaki Y, Ida I, Haga C, Akiyama H, Nakazato Y, Mikuni M.
    Neuropathology; 2008 Apr 16; 28(2):143-50. PubMed ID: 18069969
    [Abstract] [Full Text] [Related]

  • 17. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
    Chan MK, Tsang TM, Harris LW, Guest PC, Holmes E, Bahn S.
    Mol Psychiatry; 2011 Dec 16; 16(12):1189-202. PubMed ID: 20921955
    [Abstract] [Full Text] [Related]

  • 18. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC, Ozsan H, Baskak B, Devrimci Ozgüven H, Kinikli G.
    Turk Psikiyatri Derg; 2008 Dec 16; 19(1):5-12. PubMed ID: 18330738
    [Abstract] [Full Text] [Related]

  • 19. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.
    Su TP, Zhang L, Chung MY, Chen YS, Bi YM, Chou YH, Barker JL, Barrett JE, Maric D, Li XX, Li H, Webster MJ, Benedek D, Carlton JR, Ursano R.
    J Psychiatr Res; 2009 Sep 16; 43(13):1078-85. PubMed ID: 19380152
    [Abstract] [Full Text] [Related]

  • 20. Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes.
    Andersen GN, Hägglund M, Nagaeva O, Frängsmyr L, Petrovska R, Mincheva-Nilsson L, Wikberg JE.
    Scand J Immunol; 2005 Mar 16; 61(3):279-84. PubMed ID: 15787746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.